Loading…
VOYDEYA is a brand name for Danicopan, supplied as a tablet. The medicine, its uses, side effects and dosage are the same regardless of brand.
Verbatim from this product's HC label. Tap a section to expand.
2 Recommended Dose and Dosage Adjustment 10/2025 TABLE OF CONTENTS Sections or subsections that are not applicable at the time of authorization are not listed. RECENT MAJOR LABEL CHANGES ..........................................................................................
2 Part 1: Healthcare Professional Information.......................................................................... 4 1 Indications ................................................................................................................
1 Pediatrics................................................................................................................ 2 Geriatrics ................................................................................................................
4 2 Contraindications ...................................................................................................... 4 3 Serious Warnings and Precautions Box ......................................................................
4 4 Dosage and Administration ....................................................................................... 1 Dosing Considerations ...........................................................................................
2 Recommended Dose and Dosage Adjustment ...................................................... 4 Administration ....................................................................................................... 5 Missed Dose ...........................................................................................................
6 5 Overdose .................................................................................................................. 6 6 Dosage Forms, Strengths, Composition, and Packaging .............................................. 6 7 Warnings and Precautions .........................................................................................
1 Special Populations ................................................................................................ 1 Pregnancy...........................................................................................................
2 Breastfeeding ..................................................................................................... 3 Pediatrics............................................................................................................
4 Geriatrics ............................................................................................................ 9 8 Adverse Reactions .....................................................................................................
1 Adverse Reaction Overview ................................................................................... 2 Clinical Trial Adverse Reactions ........................................................................... 4 Abnormal Laboratory Findings: Hematologic, Clinical Chemistry and Other Quantitative Data.............................................................................................................
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
12 VOYDEYATM (danicopan tablets) Product Monograph Page 3 of 29 9 Drug Interactions .................................................................................................... 2 Drug Interactions Overview .................................................................................
4 Drug-Drug Interactions ........................................................................................ 5 Drug-Food Interactions ........................................................................................ 6 Drug-Herb Interactions ........................................................................................
7 Drug-Laboratory Test Interactions....................................................................... 13 10 Clinical Pharmacology ............................................................................................. 1 Mechanism of Action ...........................................................................................
2 Pharmacodynamics .............................................................................................. 3 Pharmacokinetics ................................................................................................. 14 Special Populations and Conditions .................................................................................
15 11 Storage, Stability, and Disposal ................................................................................ 16 12 Special Handling Instructions ...................................................................................
16 Part 2: Scientific Information .............................................................................................. 17 13 Pharmaceutical Information ....................................................................................
17 14 Clinical Trials ........................................................................................................... 1 Clinical Trials by Indication ..................................................................................
18 15 Microbiology ........................................................................................................... 22 16 Non-Clinical Toxicology ...........................................................................................
22 Reproductive and Developmental Toxicology: ................................................................ 23 VOYDEYATM (danicopan tablets) Product Monograph Page 4 of 29 Part 1: Healthcare Professional Information 1 Indications Voydeya (danicopan tablets) is indicated: • As an add-on to ravulizumab or eculizumab for the treatment of adult patients with paroxysmal nocturnal hemoglobinuria (PNH) who have residual hemolytic anemia due to extravascular hemolysis (EVH).
1 […]